Although cyclophilin A (CyP-A) is a relatively abundant small immunophilin present in the cytoplasm of all mammalian cells, its general function(s) in the absence of the immunosuppressant drug cyclosporine A is not known. In contrast, the high molecular weight, 
INTRODUCTION
The cyclophilins (CyPs) are members of a large protein family called immunophilins because of their ability to bind immunosuppressant drugs (reviewed in Refs. 1 and 2). The cyclophilins bind the drug cyclosporine A (CsA), and a second class of immunophilins, the FK506 binding proteins (FKBPs), bind the immunosuppressant drugs FK506 and rapamycin.
The immunophilins possess peptidylprolyl isomerase (PPIase) activity, and the immunosuppressant drugs occupy the PPIase site on the immunophilin, blocking its ability to direct cis-trans isomerization of peptidyl-prolyl bonds in vitro. CyP-A was isolated as a 17-kDa, high affinity binding protein for cyclosporine A (3), and it was later shown to be the same as a 17-kDa protein (4, 5) that was known to have PPIase activity and to accelerate refolding of ureadenatured protein in vitro (6) . CyP-A was subsequently shown to direct the immunosupressive effect of CsA (7) , and the small FKBP, FKBP12, was shown to be the target for the immunosuppressive effects of FK506 and rapamycin (8) . In both the case of CsA-bound CyP-A and that of FK506-bound FKBP12, the ultimate target of the drug-immunophilin complex is the protein phosphatase calcineurin (see Ref. 9 for review). The ultimate target for rapamycin-bound The action of these immunophilins in receptor movement is not affected by the presence of immunosuppressant drugs and thus does not require prolyl isomerase activity.
In addition to TPR domain immunophilins, GR•hsp90 heterocomplexes immunoadsorbed from cell lysates contain cytoplasmic dynein (16, 17) , a molecular motor that processes along microtubule tracks toward the nucleus (18) . In these complexes, the PPIase domain of the immunophilin functions as a protein-protein binding domain to link the GR•hsp90 unit to the protein motor (19) (20) (21) . The immunophilin linkage to cytoplasmic dynein is indirect by means of the dynamitin component of the dynein-associated dynactin complex (22) . The binding of CyP-40 or FKBP52 to dynamitin is competed by a purified PPIase domain fragment of FKBP52 (21), 5 and purified FKBP52 has been shown to bind directly via its PPIase domain to immunopurified dynamitin (22) .
There is a high degree of similarity in PPIase domain structure among the various cyclophilins (2) . The PPIase domain of bovine CyP-40, for example, shares 61% identity with the sequence of human CyP-A and, with one exception, the active site residues are identical (2).
Thus, we have asked whether CyP-A, like its high molecular weight, hsp90-binding homolog mM creatine phosphate, 20 mM magnesium acetate, and 100 units/ml of creatine phosphokinase) and the indicated peptides in HKD buffer (10 mM Hepes at pH 7.5, 100 mM KCl, 2 mM DTT).
Binding of CyP-A to Dynamitin -L929 mouse fibroblasts were grown in Dulbecco's modified Eagle's medium supplemented with 10% bovine calf serum and antibiotics. When the cells were 50% confluent, the medium was replaced by Opti-MEM transfection medium and the incubation continued for 1 h. The medium was aspirated and replaced by a transfection mixture (at a 3 µl liposome/µg of DNA ratio) preincubated for 15 min at room temperature in Opti-MEM, which contained 3 µg of the myc-tagged pCMVH50m plasmid encoding for p50/dynamitin. After To show that the binding is not a weak and possibly nonspecific interaction, reticulocyte lysate was immunoadsorbed with anti-CyP-A and the immune pellets were washed under increasingly harsh conditions. As shown in Fig. 1C 
5).
We have previously used reticulocyte lysate to achieve cell-free assembly of GR•hsp90
complexes that contain hsp90-binding immunophilins and dynein (16) . In the experiment of Lysate from bacteria expressing GST-CyP-A was added to each cytosol preparation, the mixture was incubated, and the GST-CyP-A was adsorbed to glutathione beads. As shown in condition 2
in Fig. 5 , dynein is present in GST-CyP-A pellets prepared under either condition, but tubulin is present only when GST-CyP-A is adsorbed from cytosol prepared under microtubule stabilizing conditions. If the PPIase domain fragment is present to compete for CyP-A binding to dynamitin, then neither dynein nor tubulin is present in the GST-CyP-A pellet (condition 3). This supports a 14 model in which CyP-A is linked to microtubules via its association with the dynein/dynactin complex. In Fig. 6 , 3T3 mouse fibroblasts were cotransfected with plasmids encoding for the PPIase domain fragment of FKBP52 and cyanine fluorescent protein. After 36 h, the cells were fixed and immunostained for tubulin (Fig. 6A,   green ) and CyP-A (Fig. 6B, red) . In the untransfected cells, CyP-A is seen to colocalize with tubulin (see merge in Fig. 6C ). The blue image in Fig. 6D shows a cotransfected cell in the middle of the field. Expression of the PPIase domain fragment did not affect the fibrillar pattern of the microtubules (Fig. 6A) , but it disrupted the fibrillar distribution of CyP-A (Fig. 6B) . This is consistent with the PPIase domain fragment competing for the localization of CyP-A to microtubules.
CyP-A Is Localized to Microtubules In Vivo-

DISCUSSION
We have shown here that the single domain immunophilin, CyP-A, behaves like the hsp90-binding, TPR domain immunophilins in binding to the cytoplasmic dynein motor protein complex (Fig. 1) . The PPIase domain fragment of FKBP52 competes for dynein binding, but, inasmuch as binding occurs in the presence or absence CsA (Fig. 3) , the isomerase activity of (1,2). Occasional reports have noted CyP-A association with specific proteins; for example, the YY1 suppressor of gene transcription (27) and HIV-1 Pr55gag polyprotein precursor (26, 28 
